Related Experiment Video
Updated: May 21, 2026
08:31
Bioprinting of Hydrogel Tumor Slices as a 3D Model for Mantle Cell Lymphoma
Published on: September 12, 2025
Follicular lymphoma: current management and future directions
Celeste Bello1, Ling Zhang, Mojdeh Naghashpour
1Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL 33612, USA. Celeste.Bello@moffitt.org
Cancer Control : Journal of the Moffitt Cancer Center
|June 20, 2012
Summary
Current follicular lymphoma (FL) treatments lack a definitive cure for most patients. Research is ongoing for new prognostic tests and targeted therapies to improve outcomes and reduce toxicity in FL management.
Area of Science:
- Hematology
- Oncology
- Lymphoma Research
Background:
- Follicular lymphoma (FL) is a heterogeneous lymphoid malignancy.
- Current management strategies for FL are highly individualized due to the lack of a standard of care.
- FL treatment decisions are typically based on symptom development, disease bulk, or hematologic abnormalities.
Purpose of the Study:
- To review the current scientific literature on the prognosis and management of follicular lymphoma.
- To describe recent advancements in FL treatment modalities.
- To discuss emerging trends and future directions in FL patient care.
Main Methods:
- Comprehensive review of the scientific literature.
- Analysis of prognostic factors and treatment outcomes in follicular lymphoma.
- Synthesis of data to inform future treatment strategies.
Main Results:
- No curative treatment is available for the majority of advanced-stage FL patients, except for limited-stage FL treated with radiation.
- Effective chemotherapeutic regimens exist, but none have definitively improved overall survival.
- Maintenance and consolidation therapies show promise in improving progression-free survival and potentially overall survival.
Conclusions:
- New prognostic tests are under development to better guide early treatment decisions.
- Novel targeted agents with potentially improved efficacy and reduced toxicity are under investigation.
- Future research aims to refine treatment selection and improve long-term outcomes for FL patients.
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
01:18Lymphoid Cells and Tissues
Lymphoid cells and tissues are integral to the immune system, which is crucial in maintaining our body's defense against harmful pathogens. They form the building blocks of lymphoid organs, which include the spleen, thymus, and lymph nodes.
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...
01:16Primary Lymphoid Organs
Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.